Novel Pathogenic Variants Leading to Sporadic Amyotrophic Lateral Sclerosis in Greek Patients

Genes (Basel). 2024 Feb 28;15(3):309. doi: 10.3390/genes15030309.

Abstract

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive disease that affects motor neurons, leading to paralysis and death usually 3-5 years after the onset of symptoms. The investigation of both sporadic and familial ALS highlighted four main genes that contribute to the pathogenesis of the disease: SOD1, FUS, TARDBP and C9orf72. This study aims to provide a comprehensive investigation of genetic variants found in SOD1, FUS and TARDBP genes in Greek sporadic ALS (sALS) cases. Our sequencing analysis of the coding regions of the abovementioned genes that include the majority of the variants that lead to ALS in 32 sALS patients and 3 healthy relatives revealed 6 variants in SOD1, 19 variants in FUS and 37 variants in TARDBP, of which the SOD1 p.D90A and the FUS c.*356G>A (rs886051940) variants have been previously associated with ALS, while two novel nonsense pathogenic variants were also identified, namely FUS p.R241* and TDP-43 p.Y214*. Our study contributes to the worldwide effort toward clarifying the genetic basis of sALS to better understand the disease's molecular pathology.

Keywords: FUS; SOD1; TARDBP; amyotrophic lateral sclerosis; genetics; genomic variants; sporadic ALS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis* / pathology
  • Greece
  • Humans
  • Mutation
  • Superoxide Dismutase-1 / genetics

Substances

  • Superoxide Dismutase-1

Supplementary concepts

  • Amyotrophic lateral sclerosis 1

Grants and funding

This research was funded by the Hellenic Precision Medicine Network for Neurodegenerative Diseases “https://neuropmnet.gr/?page_id=6109&lang=en; 2018SE01300001 (accessed on 7 February 2024)” and the University of Patras Research budget.